>

Edwards Lifesciences Profile

<div class='circular--portrait' style='background:#CD0D74;color: white;font-size:4em;padding-top: 25px;;'>EW</div>

Performance

0 / 100

Odds of Distress

Equity ratings for Edwards Lifesciences Corporatio are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting November 26, 2019 and ending today February 24, 2020. Click here to learn more.

Edwards Lifesciences Profile

Next fiscal quarter end is expected on March 31, 2020. Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States and internationally. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California. Edwards Lifesciences operates under Medical Devices classification in USA and is traded on BATS Exchange. It employs 13900 people. more on Edwards Lifesciences
Edwards Lifesciences Fama & French Medical Equipment
Medical Equipment
Fama & French Classification
Edwards Lifesciences SEC Filings
Edwards Lifesciences SEC Filings
Security & Exchange Commission EDGAR ReportsView All
Legal NameEdwards Lifesciences Corporatio
ChairmanMichael MussallemView All
Thematic Classifications
Active investing themes Edwards Lifesciences currently participates. An investing theme is an unweighted collection of funds, stocks, ETFs or cryptocurrencies
showing 2 out of 3 themes  View All
Average Analyst Recommendation
Current trade recommendation based on an ongoing consensus estimate among financial analysis covering Edwards Lifesciences
Piotroski F Score
Academic score to determine the current strength of Edwards Lifesciences financial position
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Horizon: 30 days (very short)Advice
Financial Strength
Edwards Lifesciences ability to generate sufficient cash flow to pay bills, repay debt, and make consistent year-to-year profit
Total Debt
Debt Current
Debt Non Current
Long Term Debt to Equity
Debt to Equity Ratio
Return on Investment
Return on Average Assets
Return on Average Equity
Return on Invested Capital
Return on Sales
Earnings per Basic Share
Earnings per Diluted Share
Price to Earnings Ratio
Earnings before Tax
Average Bond Rating: BBB-Tolerable
Profitability
Few selected profitability drivers of Edwards Lifesciences representing accounts that assess its ability to generate profits relative to its revenue, operating costs, and shareholders' equity
Consolidated Income
Net Income
Net Income Common Stock
Operating Income
Income Tax Expense
Net Income Per Employee
Operating Margin
EBITDA Margin
Gross Margin
Profit Margin
Edwards Lifesciences Corporatio (EW) is traded on BATS Exchange in USA. It is located in One Edwards Way, Irvine, CA 92614, United States and employs 13,900 people. Edwards Lifesciences is listed under Medical Equipment category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with market capitalization of 44.74 B. Edwards Lifesciences is active under Healthcare sector as part of Medical Devices industry. The entity has 207.97 M outstanding shares of which 2.04 M shares are currently sold short in the market by investors with about 1.42 days to cover all shorted shares. EDWARDS LIFESCIEN reports about 934.3 M in cash with 540.15 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.49.
Check Edwards Lifesciences Probability Of Bankruptcy

Ownership Allocation (%)

Edwards Lifesciences Target Price Odds Analysis

Odds Below 231.25HorizonTargetOdds Above 231.25
25.88%30 days 231.25 73.77%
Based on normal probability distribution, the odds of Edwards Lifesciences to move above current price in 30 days from now is about 73.77 (This Edwards Lifesciences Corporatio probability density function shows the probability of Edwards Lifesciences Stock to fall within a particular range of prices over 30 days) .

Edwards Lifesciences Top Holders

Edwards Lifesciences Corporatio Income Statement Over Time

Direct Expenses    Earning Before Interest and Taxes EBIT    Net Income    

Edwards Lifesciences Against Markets

Did you try this?

Run Companies Directory Now

   

Companies Directory

Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
All  Next Launch Module

Edwards Lifesciences Upcoming and Recent Events

Edwards Lifesciences Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportApril 28, 2020
Next Earnings ReportJuly 28, 2020
Next Fiscal Quarter EndMarch 31, 2020
Next Fiscal Year EndFebruary 4, 2021
Last Quarter Report DateDecember 31, 2019
Last Earning Anouncement DateMarch 31, 2019

Edwards Lifesciences Corporate Filings

Edwards Lifesciences SEC Reporting

Unclassified Corporate Event
Financial Statements and Exhibits. Results of Operations and Financial Condition
Other Events. Submission of Matters to a Vote of Security Holders

Edwards Lifesciences Corporate Directors

John Cardis Independent Director
Wesley Schack Presiding Independent Director
Nicholas Valeriani Independent Director
Continue to Investing Opportunities. Please also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Company logos by clearbit